Exhibit 1.2
NUVALENT, INC.
AMENDMENT NO. 1 TO
SALES AGREEMENT
October 31, 2022
Cowen and Company, LLC
599 Lexington Avenue
New York, NY 10022
Ladies and Gentlemen:
Reference is made to the Sales Agreement, dated as of August 10, 2022 (the “Original Agreement”), between Cowen and Company, LLC (“Cowen”) and Nuvalent, Inc., a Delaware corporation (the “Company”), pursuant to which the Company agreed that it may sell through Cowen, acting as agent and/or principal, shares of the Company’s Class A common stock, par value $0.0001 per share. All capitalized terms used in this Amendment No. 1 to the Original Agreement (this “Amendment”) and not otherwise defined herein shall have the respective meanings assigned to such terms in the Original Agreement. Cowen and the Company agree as follows:
| A. | The title of the Original Agreement at the top of the first page of the Original Agreement is hereby amended and restated in its entirety as follows: |
NUVALENT, INC.
$135,000,000 OF SHARES OF
CLASS A COMMON STOCK
SALES AGREEMENT
| B. | The first paragraph of section 1 of the Original Agreement is hereby amended and restated in its entirety as follows: |
1. Issuance and Sale of Shares. The Company agrees that, from time to time during the term of this Agreement, on the terms and subject to the conditions set forth herein, it may issue and sell through Cowen, acting as agent and/or principal, shares (the “Placement Shares”) of the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”), having an aggregate offering price of up to $135,000,000 (the “Maximum Amount”). Notwithstanding anything to the contrary contained herein, the parties hereto agree that compliance with the limitation set forth in this Section 1 on the number of shares of Common Stock issued and sold under this Agreement shall be the sole responsibility of the Company, and, provided it otherwise acts in accordance with its responsibilities under this Agreement and the applicable Placement Notice (as defined below), Cowen shall have no obligation in connection with such compliance. The issuance and sale of Common Stock through Cowen will be effected pursuant to the Registration Statement (as defined below) to be filed by the Company and after such Registration Statement has been declared effective by the Securities and Exchange Commission (the “Commission”), although nothing in this Agreement shall be construed as requiring the Company to use the Registration Statement (as defined below) to issue the Common Stock.